Canada Markets open in 1 hr 23 mins

Onxeo SA (ALONX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.4305-0.0025 (-0.58%)
As of 01:32PM CET. Market open.
Full screen
Previous Close0.4330
Open0.4250
BidN/A x N/A
AskN/A x N/A
Day's Range0.4250 - 0.4400
52 Week Range0.1262 - 0.7500
Volume182,755
Avg. Volume637,734
Market Cap39.477M
Beta (5Y Monthly)1.33
PE Ratio (TTM)43.05
EPS (TTM)0.0100
Earnings DateSept 13, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.93
  • Business Wire

    Onxeo Announces its Financial Agenda for 2023

    PARIS, January 27, 2023--Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX) (Paris:ALONX), ("Onxeo" or "the Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) and driver oncogenes, today announced its financial agenda for 2023.

  • Business Wire

    ONXEO Provides Update on the Development Program For Its First-in-class Drug Candidate AsiDNATM

    PARIS, January 25, 2023--Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX) (Paris:ALONX), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development of innovative tumor specific drugs targeting tumor DNA Damage Response (DDR) and driver oncogenes, today provides an update on the clinical development program of its first-in-class drug candidate AsiDNATM.

  • Business Wire

    Onxeo: Extraordinary General Meeting of February 6, 2023: Availability of Preparatory Documents

    PARIS, January 18, 2023--Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX), hereafter "Onxeo" or the "Company", a clinical stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA damage response (DDR) mechanisms to fight rare or resistant cancers, today announces the availability of the preparatory documents for its Extraordinary General Meeting which will be held on Monday, February 6, 2023 at 2:00 p.m. at the Renaissance Paris Nobel Tour Eif